Literature DB >> 20484954

Incidental pancreatic cysts: do we really know what we are watching?

Camilo Correa-Gallego1, Cristina R Ferrone, Sarah P Thayer, Jennifer A Wargo, Andrew L Warshaw, Carlos Fernández-Del Castillo.   

Abstract

BACKGROUND: Most cystic neoplasms of the pancreas (CNPs) are incidentally discovered. Their management continues to be debated and preoperative diagnosis is often inaccurate.
METHODS: Retrospective review of 330 patients with incidentally discovered CNPs. Preoperative and final histological diagnoses were correlated.
RESULTS: 41% (136/330) of patients were operated on at diagnosis. 50 patients underwent resection for a presumed branch-duct (Bd) intraductal papillary mucinous neoplasm (IPMN), which was confirmed in only 64% (32/50); of the remaining patients, 20% had main-duct involvement. Mucinous cystic neoplasm was the preoperative diagnosis in 30/136 patients, histologic examination was confirmatory in only 60% (18/30). Most lesions presumed to be main-duct or combined IPMNs or serous cystadenomas were confirmed as such after resection (15/16 and 11/12, respectively). Multifocality was not only associated with Bd-IPMN, and 5% of all cysts were non-neoplastic. Overall, in only 68% of cases did the preoperative and histological diagnoses match.
CONCLUSIONS: In an experienced, high-volume center, preoperative diagnosis was incorrect in one-third of incidentally discovered CNPs who underwent resection. Of particular concern, 20% of presumed Bd-IPMN had a main-duct component. Conversely, 5% of resected cysts were not even neoplastic. Clearly, better diagnostic methods are needed to aid in formulating appropriate treatment strategies. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20484954      PMCID: PMC3214832          DOI: 10.1159/000243733

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  10 in total

Review 1.  International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.

Authors:  Masao Tanaka; Suresh Chari; Volkan Adsay; Carlos Fernandez-del Castillo; Massimo Falconi; Michio Shimizu; Koji Yamaguchi; Kenji Yamao; Seiki Matsuno
Journal:  Pancreatology       Date:  2006       Impact factor: 3.996

2.  Fluid CEA in IPMNs: A useful test or the flip of a coin?

Authors:  Camilo Correa-Gallego; Andrew L Warshaw; Carlos Fernandez-del Castillo
Journal:  Am J Gastroenterol       Date:  2009-02-17       Impact factor: 10.864

Review 3.  Pancreatic imaging: current state of the art.

Authors:  Timothy P Kinney; Martin L Freeman
Journal:  Gastroenterology       Date:  2009-01-23       Impact factor: 22.682

4.  Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients.

Authors:  Carlos Fernández-del Castillo; Javier Targarona; Sarah P Thayer; David W Rattner; William R Brugge; Andrew L Warshaw
Journal:  Arch Surg       Date:  2003-04

5.  A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients.

Authors:  Peter J Allen; Michael D'Angelica; Mithat Gonen; David P Jaques; Daniel G Coit; William R Jarnagin; Ronald DeMatteo; Yuman Fong; Leslie H Blumgart; Murray F Brennan
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

6.  Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.

Authors:  Roberto Salvia; Carlos Fernández-del Castillo; Claudio Bassi; Sarah P Thayer; Massimo Falconi; William Mantovani; Paolo Pederzoli; Andrew L Warshaw
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

7.  Incidental cystic neoplasms of pancreas: what is the optimal interval of imaging surveillance?

Authors:  Ananya Das; Christopher D Wells; Cuong C Nguyen
Journal:  Am J Gastroenterol       Date:  2008-06-28       Impact factor: 10.864

8.  Current trends in pancreatic cystic neoplasms.

Authors:  Cristina R Ferrone; Camilo Correa-Gallego; Andrew L Warshaw; William R Brugge; David G Forcione; Sarah P Thayer; Carlos Fernández-del Castillo
Journal:  Arch Surg       Date:  2009-05

9.  Prevalence of unsuspected pancreatic cysts on MDCT.

Authors:  Thomas A Laffan; Karen M Horton; Alison P Klein; Bruce Berlanstein; Stanley S Siegelman; Satomi Kawamoto; Pamela T Johnson; Elliot K Fishman; Ralph H Hruban
Journal:  AJR Am J Roentgenol       Date:  2008-09       Impact factor: 3.959

10.  Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Thomas Schnelldorfer; Michael G Sarr; David M Nagorney; Lizhi Zhang; Thomas C Smyrk; Rui Qin; Suresh T Chari; Michael B Farnell
Journal:  Arch Surg       Date:  2008-07
  10 in total
  68 in total

1.  Pancreatic cystic lesions: How endoscopic ultrasound morphology and endoscopic ultrasound fine needle aspiration help unlock the diagnostic puzzle.

Authors:  Luca Barresi; Ilaria Tarantino; Antonino Granata; Gabriele Curcio; Mario Traina
Journal:  World J Gastrointest Endosc       Date:  2012-06-16

2.  miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts.

Authors:  Hanno Matthaei; Dennis Wylie; Maura B Lloyd; Marco Dal Molin; Jon Kemppainen; Skye C Mayo; Christopher L Wolfgang; Richard D Schulick; Laura Langfield; Bernard F Andruss; Alex T Adai; Ralph H Hruban; Anna E Szafranska-Schwarzbach; Anirban Maitra
Journal:  Clin Cancer Res       Date:  2012-06-21       Impact factor: 12.531

Review 3.  IPMN: surgical treatment.

Authors:  Reto M Käppeli; Sascha A Müller; Bianka Hummel; Christina Kruse; Philip Müller; Jürgen Fornaro; Alexander Wilhelm; Marcel Zadnikar; Bruno M Schmied; Ignazio Tarantino
Journal:  Langenbecks Arch Surg       Date:  2013-09-03       Impact factor: 3.445

Review 4.  [Surgical therapy of intraductal papillary mucinous neoplasms of the pancreas].

Authors:  S Fritz; M W Büchler; J Werner
Journal:  Chirurg       Date:  2012-02       Impact factor: 0.955

Review 5.  Novel Biomarkers for Pancreatic Cysts.

Authors:  Harkirat Singh; Kevin McGrath; Aatur D Singhi
Journal:  Dig Dis Sci       Date:  2017-02-14       Impact factor: 3.199

Review 6.  Molecular Diagnostics and Testing for Pancreatic Cysts.

Authors:  Jaime de la Fuente; Shounak Majumder
Journal:  Curr Treat Options Gastroenterol       Date:  2020-01-27

7.  Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts.

Authors:  Sam L Ivry; Jeremy M Sharib; Dana A Dominguez; Nilotpal Roy; Stacy E Hatcher; Michele T Yip-Schneider; C Max Schmidt; Randall E Brand; Walter G Park; Matthias Hebrok; Grace E Kim; Anthony J O'Donoghue; Kimberly S Kirkwood; Charles S Craik
Journal:  Clin Cancer Res       Date:  2017-04-19       Impact factor: 12.531

8.  Natural History of Patients Followed Radiographically with Mucinous Cysts of the Pancreas.

Authors:  Linda M Pak; Michael I D'Angelica; Ronald P DeMatteo; T Peter Kingham; Vinod P Balachandran; William R Jarnagin; Peter J Allen
Journal:  J Gastrointest Surg       Date:  2017-05-17       Impact factor: 3.452

9.  GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs".

Authors:  Hanno Matthaei; Jian Wu; Marco Dal Molin; Chanjuan Shi; Sven Perner; Glen Kristiansen; Philipp Lingohr; Jörg C Kalff; Christopher L Wolfgang; Kenneth W Kinzler; Bert Vogelstein; Anirban Maitra; Ralph H Hruban
Journal:  Am J Surg Pathol       Date:  2014-03       Impact factor: 6.394

10.  Intraductal papillary mucinous neoplasms of the pancreas: radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines.

Authors:  Albert Strauss; Matthew Birdsey; Stefan Fritz; Bogata D Schwarz-Bundy; Frank Bergmann; Thilo Hackert; Hans-Ullrich Kauczor; Lars Grenacher; Miriam Klauss
Journal:  Br J Radiol       Date:  2016-03-09       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.